Clinical Trials Directory

Trials / Unknown

UnknownNCT04285060

Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke

Safety and Efficacy on Functional Mobility Following Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke: A Pivotal Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Samsung Electronics · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

A single-site, interventional, single-arm trial to evaluate the safety and efficacy on functional mobility following Samsung GEMS-H (Gait Enhancing and Motivating System - Hip) device training in participants with sub-acute and chronic stroke.

Conditions

Interventions

TypeNameDescription
DEVICESamsung GEMS-HSubjects will participate in 18 sessions of training in the outpatient clinic with a licensed physical therapist. Therapy sessions will include 30 minutes of task specific training and another 15 minutes of the session can be used to focus on patient specific goal areas related to functional mobility and balance. Training sessions will occur 2-3 times a week for 6-8 weeks to complete the training protocol.

Timeline

Start date
2020-02-12
Primary completion
2021-11-01
Completion
2021-12-01
First posted
2020-02-26
Last updated
2021-09-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04285060. Inclusion in this directory is not an endorsement.

Safety and Efficacy of Samsung GEMS-H Device Training in Sub-Acute and Chronic Stroke (NCT04285060) · Clinical Trials Directory